Chloroquine in fighting COVID-19: good, bad, or both?

Daolin Tang, Jingbo Li, Ruoxi Zhang, Rui Kang, Daniel J. Klionsky

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.

Original languageEnglish (US)
Pages (from-to)2273-2275
Number of pages3
Issue number12
StatePublished - 2020


  • COVID-19
  • Chloroquine
  • SARS-CoV-2
  • autophagy
  • clinical trial
  • hydroxychloroquine

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Chloroquine in fighting COVID-19: good, bad, or both?'. Together they form a unique fingerprint.

Cite this